Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
400 Seaport Court, Redwood City, CA, 94063, United States
Market Cap
26.71M
52 Wk Range
$3.10 - $13.37
Previous Close
$4.18
Open
$4.08
Volume
8,450
Day Range
$4.08 - $4.29
Enterprise Value
23.07M
Cash
3.746M
Avg Qtr Burn
-1.147M
Insider Ownership
35.38%
Institutional Own.
2.33%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Burixafor Details Multiple myeloma | Phase 2 Update |